Skip to main content
An official website of the United States government
Email

Current Showcase Companies

Each year, NCI SBIR conducts a private-sector peer review with more than 70 third-party investors and strategic partners to determine which companies in the NCI SBIR portfolio are ready to attract financing and/or partnerships. Below, we present the 30 companies selected for 2024. These companies will be attending and pitching at leading investor conferences through the summer of 2025.

If you are an investor or company interested in learning more about any of the companies, you can find their contact information below or contact Brittany Connors for more information or a direct introduction.

Biopharmaceuticals

  • 7 Hills Pharma_ Investor Initiatives-2024

    7 Hills Pharma

    Houston, TX
    Small Molecule
    Upendra Marathi | upendra@7hillspharma.com

  • Allterum Therapeutics (Fannin Partners)

    Allterum Therapeutics

    Houston, TX
    Biologics/Vaccine
    Atul Varadhachary | atul@fannininnovation.com

  • Canget BioTekpharma _ Investor Initiatives-2024

    Canget BioTekpharma

    Buffalo, NY
    Small Molecule
    John Seman | john.seman@canget-biotek.com

  • Cellinfinity _ Investor Initiatives-2024

    Cellinfinity

    New Haven, CT
    Cell/Gene Therapy
    Premal Patel | premal.patel@cellinfinitybio.com

  • Duo Oncology _ Investor Initiatives-2024

    Duo Oncology

    Pittsburgh, PA
    Small Molecule
    Sam Rothstein | srothstein@duooncology.com

  • Kovina Therapeutics _ Investor Initiatives-2024

    Kovina Therapeutics

    Indianapolis, IN
    Small Molecule
    Kristin Sherman | kristin.sherman@kovina.com

  • Mabswitch _ Investor Initiatives-2024

    Mabswitch

    Los Angeles, CA
    Cell/Gene Therapy
    Yemi Onakunle | yemi.onakunle@mabswitch.com

  • miRecule _ Investor Initiatives-2024

    miRecule

    Gaithersburg, MD
    Biologics/Vaccine
    Anthony Saleh | anthony@miRecule.com

  • pacDNA Therapeutics _ Investor Initiatives-2024

    pacDNA Therapeutics

    Boston, MA
    Small Molecule
    Car LeBel | c.lebel@pacdnatx.com

  • Resolute Science _ Investor Initiatives-2024

    Resolute Science

    San Diego, CA
    Small Molecule (Drug/Delivery Platform)
    Faith Barnett | fbarnett@resolutescience.com

  • Saros Therapeutics _ Investor Initiatives-2024

    Saros Therapeutics

    Chicago, IL
    Small Molecule
    Matt Martin | mmartin@sarostx.com

  • Stingray Therapeutics

    Stingray Therapeutics

    Houston, TX
    Small Molecule
    Jonathan Northrup | jon@stingraytx.com

  • Symphony Biosciences _ Investor Initiatives-2024

    Symphony Biosciences

    Los Angeles, CA
    Drug/Delivery Device
    Negin Majedi | negin@symphonybiosciences.com

  • Tezcat Biosciences _ Investor Initiatives-2024

    Tezcat Biosciences

    New York, NY
    Biologics/Vaccine (Protein-Drug Conjugate)
    Craig Ramirez | craig@tezcat.co

  • TrAMPoline Pharma _ Investor Initiatives-2024

    TrAMPoline Pharma

    Aurora, CO
    Cell/Gene Therapy
    Richard Duke | rduke@trampolinepharma.com

Devices

  • Ananya Health _ Investor Initiatives-2024

    Ananya Health

    Berkeley, CA
    Surgical/Ablative Device
    Anu Parvatiyar | anu@ananya.health

  • Calla Health Foundationv_ Investor Initiatives-2024

    Calla Health Foundation

    Durham, NC
    Cancer Screening and Diagnosis Device
    Marlee Krieger | marlee@callahealthfoundation.com

  • CivaTech Oncology _ Investor Initiatives-2024

    CivaTech Oncology

    Research Triangle Park, NC
    Radiation Therapy Device
    Suzanne Babcock | sbabcock@civatechoncology.com

  • Eisana Health _ Investor Initiatives-2024

    Eisana Health

    The Woodlands, TX
    At Home/In Clinic Device
    Carole Spangler Vaughn | carole@eisana.com

  • Magnetic Insight _ Investor Initiatives-2024

    Magnetic Insight

    Alameda, CA
    Imaging Device
    Chris Raanes | chris.raanes@magneticinsight.com

  • Ramona Optics _ Investor Initiatives-2024

    Ramona Optics

    Durham, NC
    Imaging Device
    Gregor Horstmeyer | gregor@ramonaoptics.com

  • TibaRay _ Investor Initiatives-2024

    TibaRay

    Fremont, CA
    Hospital Device
    Jeff Amacker | jeff@tibaray.com

Diagnostics/Tools

  • Amplified Sciences _ Investor Initiatives-2024

    Amplified Sciences

    West Lafayette, IN
    In Vitro Diagnostic
    Diana Caldwell | diana.caldwell@amplifiedsci.com

  • Applikate Technologies _ Investor Initiatives-2024

    Applikate Technologies

    Fairfield, CT
    In Vitro Diagnostic Tissue Imaging Device and Image Management Software
    Richard Torres | richard.torres@applikate.com

  • AtlasXomics _ Investor Initiatives-2024

    AtlasXomics

    New Haven, CT
    Research Tool
    Ken Wang | kenw@atlasxomics.com

  • Precision Epigenomics _ Investor Initiatives-2024

    Precision Epigenomics

    Tucson, AZ
    In Vitro Diagnostic
    Mark Nelson | manelson@precision-epigenomics.com

  • Stem Pharm _ Investor Initiatives-2024

    Stem Pharm

    Madison, WI
    Drug Development Tool
    Steven Visuri | steven.visuri@stempharm.com

Digital Health

  • Alara Imaging _ Investor Initiatives-2024

    Alara Imaging

    Westport, CT
    San Francisco, CA
    Nate Mazonson | nate@alaragateway.com

  • Gradient Health _ Investor Initiatives-2024

    Gradient Health

    Durham, NC
    Bioinformatics Software: Algorithms & AI
    Joshua Miller | josh@gradienthealth.io

  • mPath _ Investor Initiatives-2024

    mPath

    Winston-Salem, NC
    Digital Health Educational Tool
    Dave Miller | dave@mpathhealth.com

Email